Mycostatin (Ready Mixed) (Nystatin)

Nystatin, the active ingredient in Mycostatin (Ready Mixed), is a polyene antifungal presented as a ready mixed oral suspension for oral use. It treats oral, esophageal and intestinal candidiasis in patients with fungal infections.

GNH USA supplies Mycostatin (Ready Mixed) as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nystatin is used to treat fungal infections of the mucous membranes and gastrointestinal tract.

Oral candidiasis (thrush): reduces fungal load and resolves oral lesions. Esophageal candidiasis: eradicates Candida species and promotes healing of esophageal lesions. Intestinal candidiasis: controls overgrowth of Candida in the gut and alleviates related gastrointestinal symptoms.

Nystatin may cause adverse reactions, most of which are mild and localized to the gastrointestinal tract.

Common Side Effects: - Nausea: mild stomach discomfort or queasiness. - Vomiting: occasional expulsion of stomach contents. - Diarrhea: loose stools occurring during treatment. - Abdominal pain: cramping or discomfort in the stomach area. - Taste alteration: temporary change in taste perception.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or hives. - Anaphylaxis: life‑threatening systemic allergic response (very rare).

When using Mycostatin (Ready Mixed), consider the following precautions.

Pregnancy: safety not established; use only if clearly needed. Breastfeeding: unknown; weigh benefits against potential risks. Renal impairment: monitor as drug is excreted unchanged. Concomitant antibiotics: may alter gut flora, monitor for overgrowth. Store at below 25°C: keep in the original container, protect from moisture and light.

Mycostatin (Ready Mixed) can interact with other medicines; review the following.

Major Interactions (Avoid): - Broad-spectrum antibiotics: may disrupt normal flora and increase risk of fungal overgrowth. - Antacids containing aluminum or magnesium: can reduce suspension absorption.

Moderate Interactions (Monitor Closely): - Oral contraceptives: theoretical reduction in efficacy, monitor menstrual changes. - Immunosuppressants: increased risk of systemic fungal infection, monitor patient status. - Probiotics: may affect gut microbiome balance, observe for symptoms.